Characterization of VIP36, an animal lectin homologous to leguminous lectins

1996 ◽  
Vol 109 (1) ◽  
pp. 271-276 ◽  
Author(s):  
K. Fiedler ◽  
K. Simons
Keyword(s):  
Golgi Apparatus ◽  
Recombinant Protein ◽  
Secretory Pathway ◽  
Mdck Cells ◽  
Membrane Structures ◽  
New Family ◽  
Legume Lectin ◽  
Animal Lectin

VIP36 was isolated from MDCK cells as a component of glycolipid-enriched detergent-insoluble complexes. The protein is localized to the Golgi apparatus and the cell surface, and belongs to a new family of legume lectin homologues in the animal secretory pathway that might be involved in the trafficking of glycoproteins, glycolipids or both. Here we show that VIP36 is N-glycosylated and expressed in organs abundant in epithelial cells as well as in non-epithelial organs. Our studies demonstrate that the recombinant exoplasmic/luminal domain of VIP36 binds Ca2+ and that the protein decorates internal membrane structures of MDCK cells in vitro that are distinct from the Golgi apparatus. This binding requires Ca2+ and can be specifically inhibited by N-acetyl-D-galactosamine. The recombinant protein was used for affinity chromatography. Glycopeptides obtained from [3H]galactose-labelled cells bind to VIP36 and can be eluted with N-acetyl-D-galactosamine. Our data imply that VIP36 functions as a lectin in post-Golgi trafficking.

Insights into the Secretory Pathway, the Mechanism of Terminal Glycosylation and Intracellular Peptide Hormone Receptors from Studies on Hepatic Golgi Fractions

1981 ◽  
Vol 39 ◽  
pp. 516-519
Author(s):  
J.J.M. Bergeron ◽  
B.I. Posner ◽  
Jacques Paiement ◽  
R. Sikstrom ◽  
M. Khan
Keyword(s):  
Golgi Apparatus ◽  
Plasma Proteins ◽  
Secretory Pathway ◽  
Hormone Receptors ◽  
Peptide Hormone ◽  
Secretory Protein ◽  
Golgi Membrane ◽  
Membrane Structures

Recent studies on purified subcellular fractions of hepatic Golgi apparatus have provided insight into the functioning of the Golgi apparatus in vivo.The hepatocyte is the site of synthesis of most circulating plasma proteins. On a total protein basis, purified Golgi fractions revealed mainly secretory content (albumin, transferrin and other plasma proteins) as major constituents. After an in vivo injection of radiolabeled leucine, newly synthesized secretory protein followed a temporal route from cis to trans regions of Golgi apparatus before appearance in the plasma. This route was revealed by studies on disrupted Golgi fractions enriched in disparate regions of the Golgi apparatus.The terminal glycosylation of secretory glcyoproteins (e.g. transferrin) can be studied by observing the transfer of UDP-(3H)-galactose to endogenous acceptors within Golgi fractions. Transfer was shown to occur to a glycolipid (dolichyl galactosyl phosphate) probably on the cytosolic aspect of the Golgi membrane. Translocation of the labeled galactose across the membrane coincided with fusion of Golgi saccules in vitro. It is felt that during the process of Golgi membrane fusion, inverted lipid- micellar membrane structures translocate the dolichyl galactosyl phosphate from a cytosolic to a luminal orientation. Luminally oriented dolichyl galactosyl phosphate would then serve as substrate for galactose transfer to intraluminal glycopeptide acceptors via intraluminal galactosyl transferase enzyme.

Role for ICAT in β-catenin-dependent nuclear signaling and cadherin functions

2004 ◽  
Vol 286 (4) ◽  
pp. C747-C756 ◽  
Author(s):  
Cara J. Gottardi ◽  
Barry M. Gumbiner
Keyword(s):  
Cultured Cells ◽  
Mdck Cells ◽  
Primary Role ◽  
Protein Levels ◽  
Nuclear Signaling ◽  
Endogenous Protein ◽  
Hepatocyte Growth Factor Treatment

Inhibitor of β-catenin and TCF-4 (ICAT) is a 9-kDa polypeptide that inhibits β-catenin nuclear signaling by binding β-catenin and competing its interaction with the transcription factor TCF (T cell factor), but basic characterization of the endogenous protein and degree to which it alters other β-catenin functions is less well understood. At the subcellular level, we show that ICAT localizes to both cytoplasmic and nuclear compartments. In intestinal tissue, ICAT is upregulated in the mature, nondividing enterocyte population lining intestinal villi and is absent in the β-catenin/TCF signaling-active crypt region, suggesting that its protein levels may be inversely related with β-catenin signaling activity. However, ICAT protein levels are not altered by activation or inhibition of Wnt signaling in cultured cells, suggesting that ICAT expression is not a direct target of the Wnt/β-catenin pathway. In cells where β-catenin levels are elevated by Wnt, a fraction of this β-catenin pool is associated with ICAT, suggesting that ICAT may buffer the cell from increased levels of β-catenin. Distinct from TCF and cadherin, ICAT does not protect the soluble pool of β-catenin from degradation by the adenomatous polyposis coli containing “destruction complex.” Although ICAT inhibits β-catenin binding to the cadherin as well as TCF in vitro, stable overexpression of ICAT in Madin-Darby canine kidney (MDCK) epithelial cells shows no obvious alterations in the cadherin complex, suggesting that the ability of ICAT to inhibit β-catenin binding to the cadherin may be restricted in vivo. MDCK cells overexpressing ICAT do, however, exhibit enhanced cell scattering on hepatocyte growth factor treatment, suggesting a possible role in the regulation of dynamic rather than steady-state cell-cell adhesions. These findings confirm ICAT's primary role in β-catenin signaling inhibition and further suggest that ICAT may have consequences for cadherin-based adhesive function in certain circumstances, implying a broader role than previously described.

scholarly journals Identification and Characterization of a Novel Heme-Associated Cell Surface Protein Made by Streptococcus pyogenes

2002 ◽  
Vol 70 (8) ◽  
pp. 4494-4500 ◽  
Author(s):  
Benfang Lei ◽  
Laura M. Smoot ◽  
Heather M. Menning ◽  
Jovanka M. Voyich ◽  
Subbarao V. Kala ◽  
...  
Keyword(s):  
Recombinant Protein ◽  
Cell Surface ◽  
Surface Protein ◽  
Cell Surface Protein ◽  
Gene Encoding ◽  
Invasive Infections ◽  
Group A

ABSTRACT Analysis of the genome sequence of a serotype M1 group A Streptococcus (GAS) strain identified a gene encoding a previously undescribed putative cell surface protein. The gene was cloned from a serotype M1 strain, and the recombinant protein was overexpressed in Escherichia coli and purified to homogeneity. The purified protein was associated with heme in a 1:1 stoichiometry. This streptococcal heme-associated protein, designated Shp, was produced in vitro by GAS, located on the bacterial cell surface, and accessible to specific antibody raised against the purified recombinant protein. Mice inoculated subcutaneously with GAS and humans with invasive infections and pharyngitis caused by GAS seroconverted to Shp, indicating that Shp was produced in vivo. The blood of mice actively immunized with Shp had significantly higher bactericidal activity than the blood of unimmunized mice. The shp gene was cotranscribed with eight contiguous genes, including homologues of an ABC transporter involved in iron uptake in gram-negative bacteria. Our results indicate that Shp is a novel cell surface heme-associated protein.

Characterization of a new family of protein kinases from Arabidopsis containing phosphoinositide 3/4-kinase and ubiquitin-like domains

2007 ◽  
Vol 409 (1) ◽  
pp. 117-127 ◽  
Author(s):  
Rafaelo M. Galvão ◽  
Uma Kota ◽  
Erik J. Soderblom ◽  
Michael B. Goshe ◽  
Wendy F. Boss
Keyword(s):  
Protein Kinases ◽  
Ubiquitin Proteasome System ◽  
Lipid Kinase ◽  
Protein Substrates ◽  
New Family ◽  
Thale Cress ◽  
Ubiquitin Proteasome ◽  
Vitro Analysis

At least two of the genes predicted to encode type II PI4K (phosphoinositide 4-kinase) in Arabidopsis thaliana (thale cress), namely AtPI4Kγ4 and AtPI4Kγ7, encode enzymes with catalytic properties similar to those of members of the PIKK (phosphoinositide kinase-related kinase) family. AtPI4Kγ4 and AtPI4Kγ7 undergo autophosphorylation and phosphorylate serine/threonine residues of protein substrates, but have no detectable lipid kinase activity. AtPI4Kγ4 and AtPI4Kγ7 are members of a subset of five putative AtPI4Ks that contain N-terminal UBL (ubiquitin-like) domains. In vitro analysis of AtPI4Kγ4 indicates that it interacts directly with, and phosphorylates, two proteins involved in the ubiquitin–proteasome system, namely UFD1 (ubiquitin fusion degradation 1) and RPN10 (regulatory particle non-ATPase 10). On the basis of the present results, we propose that AtPI4Kγ4 and AtPI4Kγ7 should be designated UbDKγ4 and UbDKγ7 (ubiquitin-like domain kinases γ4 and γ7). These UBL-domain-containing AtPI4Ks correspond to a new PIKK subfamily of protein kinases. Furthermore, UFD1 and RPN10 phosphorylation represents an additional mechanism by which their function can be regulated.

VIP36 localisation to the early secretory pathway

1999 ◽  
Vol 112 (17) ◽  
pp. 2813-2821 ◽  
Author(s):  
J. Fullekrug ◽  
P. Scheiffele ◽  
K. Simons
Keyword(s):  
Secretory Pathway ◽  
Mdck Cells ◽  
Brefeldin A ◽  
Vero Cells ◽  
Integral Membrane Protein ◽  
Membrane Structures ◽  
Early Secretory Pathway ◽  
Marker Proteins ◽  
Partial Overlap ◽  
Cytoplasmic Structures

VIP36, an integral membrane protein previously isolated from epithelial MDCK cells, is an intracellular lectin of the secretory pathway. Overexpressed VIP36 had been localised to the Golgi complex, plasma membrane and endocytic structures suggesting post-Golgi trafficking of this molecule (Fiedler et al., 1994). Here we provide evidence that endogenous VIP36 is localised to the Golgi apparatus and the early secretory pathway of MDCK and Vero cells and propose that retention is easily saturated. High resolution confocal microscopy shows partial overlap of VIP36 with Golgi marker proteins. Punctate cytoplasmic structures colocalise with coatomer and ERGIC-53, labeling ER-Golgi intermediate membrane structures. Cycling of VIP36 is suggested by colocalisation with anterograde cargo trapped in pre-Golgi structures and modification of its N-linked carbohydrate by glycosylation enzymes of medial Golgi cisternae. Furthermore, after brefeldin A treatment VIP36 is segregated from resident Golgi proteins and codistributes with ER-Golgi recycling proteins.

Sign in / Sign up

Export Citation Format

Share Document